Veronique Meignin
Overview
Explore the profile of Veronique Meignin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1563
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lordello L, Nuan-Aliman S, Kielbassa-Elkadi K, Montagne A, Kotta K, Martins I, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941763
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, characterized by aggressive and heterogeneous tumors originating from B-cells. Especially in patients with relapsed or refractory (R/R)...
2.
Vercellino L, Betterki S, Blanc E, De Kerviler E, Cristinelli C, Merlet P, et al.
Br J Radiol
. 2024 Sep;
97(1163):1755-1764.
PMID: 39235920
CAR T-cells is an innovative treatment for relapsed/refractory aggressive B cell lymphomas, initially proposed as third-line therapy and beyond, now allowed as soon as second-line treatment for patients with early...
3.
Stammler R, Vacher L, Fournier B, Lemaire P, Chauvel C, Silvestrini M, et al.
J Med Virol
. 2024 Jul;
96(8):e29836.
PMID: 39078052
Primary effusion lymphoma (PEL) is a rare B-cell non-Hodgkin lymphoma associated with Kaposi Sarcoma-associated herpesvirus (KSHV/HHV8) infection. Lymphoma cells are coinfected with Epstein-Barr virus (EBV) in 60-80% of cases. Tools...
4.
Ito Y, Marouf A, Kogure Y, Koya J, Lievin R, Bruneau J, et al.
Cancer Res
. 2024 Apr;
84(13):2181-2201.
PMID: 38657099
Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm with male dominance and a poor prognosis. A better understanding of the genetic alterations and their functional roles in ENKTCL...
5.
Bordat J, Suarez F, Cormier-Daire V, Peffault de Latour R, Soulier J, Meignin V, et al.
Haematologica
. 2024 Mar;
109(8):2665-2670.
PMID: 38497148
No abstract available.
6.
Unmasking Bartonella henselae infection in the shadows of long COVID thanks to clinical metagenomics
Aubry A, Corvilain E, Ghelfenstein-Ferreira T, Camelena F, Meignin V, Bercot B, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Mar;
43(5):1025-1029.
PMID: 38472519
The diagnosis of long COVID often relies on symptoms post-COVID-19, occasionally lacking biological evidence. This case study illustrates how investigating long COVID uncovered an underlying bartonellosis through clinical metagenomics. Following...
7.
Gou P, Liu D, Ganesan S, Lauret E, Maslah N, Parietti V, et al.
Blood Cancer J
. 2024 Jan;
14(1):1.
PMID: 38177095
Classical myeloproliferative neoplasms (MPNs) are characterized by the proliferation of myeloid cells and the risk of transformation into myelofibrosis or acute myeloid leukemia (AML) and TP53 mutations in MPN patients...
8.
Rasmussen C, Gerard L, Fadlallah J, Corvilain E, Galicier L, Meignin V, et al.
Blood Adv
. 2023 Jun;
7(18):5663-5669.
PMID: 37288720
Rituximab has revolutionized the treatment of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated multicentric Castleman disease (HHV8+ MCD), converting a rapidly fatal illness into a relapsing disease. HHV8+ MCD mainly affects patients...
9.
Dieudonne Y, Silvestrini M, Dossier A, Meignin V, Jouenne F, Mahevas T, et al.
Br J Haematol
. 2023 May;
202(2):267-278.
PMID: 37221131
Unicentric Castleman disease (UCD) is a lymphoproliferative disease of unknown cause. Paraneoplastic pemphigus (PNP) is a major complication shown to be associated with a poor prognosis, with particular severity in...
10.
Armand M, Degaud M, Tesson B, Laurent C, Vavasseur M, Parisot M, et al.
Leukemia
. 2023 Mar;
37(6):1388-1391.
PMID: 36914771
No abstract available.